SK15695A3 - Preparing method of 3{2-£4-(6-fluorobenzo £d|-isoxazole-3-yl piperidine-1-yl| ethyl}-2-methyl-6,7,8,9-tetrahydro-4-h-pyridole pyridole £1,2-a| pyrimidine-4-on - Google Patents

Preparing method of 3{2-£4-(6-fluorobenzo £d|-isoxazole-3-yl piperidine-1-yl| ethyl}-2-methyl-6,7,8,9-tetrahydro-4-h-pyridole pyridole £1,2-a| pyrimidine-4-on Download PDF

Info

Publication number
SK15695A3
SK15695A3 SK156-95A SK15695A SK15695A3 SK 15695 A3 SK15695 A3 SK 15695A3 SK 15695 A SK15695 A SK 15695A SK 15695 A3 SK15695 A3 SK 15695A3
Authority
SK
Slovakia
Prior art keywords
formula
tetrahydro
methyl
pyrimidin
pyrido
Prior art date
Application number
SK156-95A
Other languages
Slovak (sk)
Other versions
SK281752B6 (en
Inventor
Barjoan P Dalmases
Olondriz F Marquillas
Clotet J Huguet
Rovira A Bosch
Castillo Nieto Juan C Del
Ges Jose M Caldero
Original Assignee
Vita Invest Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest Sa filed Critical Vita Invest Sa
Publication of SK15695A3 publication Critical patent/SK15695A3/en
Publication of SK281752B6 publication Critical patent/SK281752B6/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Disclosed is a method for preparation of 3-{2-[4-(6-fluorine-benzo [d] isoxasol-3-yl) piperidine-1-yl]ethyl}-methyl-6,7,8,6-tetrahydro-4H- pyridol[1,2-a]pyrimindin-4-one of formula (I) by reaction 3-(2-amino-ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido- [1,2-a]pyrimidin-4-one of formula (II) with compound of formula (III), wherein Y and Z are same or each other different releasing groups such is halogen or C1-6 alkyl or phenyl-sulphonyloxy group under the presence of dissolvent and alkali. Disclosed are also compounds of formula (II) and formula (III), wherein Z and Y are of the said meaning, as intermediates of the method for preparation of compound of formula (I).

Description

Spôsob prípravy 3-{2-[4-( 6-fluórbenzo [d] izoxazol-3-yl) piperidin-1 -ylj etyl}-2-metyl-5,7,8,9-tetrahydro-4H-pyrido [i ,2-aj pyrimidin-4-ónuPreparation of 3- {2- [4- (6-fluorobenzo [d] isoxazol-3-yl) piperidin-1-yl] ethyl} -2-methyl-5,7,8,9-tetrahydro-4H-pyrido [i] 2-pyrimidin-4-one

Oblasť technikyTechnical field

Vynález sa týka spôsobu prípravy 3-{2-[4-(6-fluórbenzo[dj izoxazol-3-yl) piperidin-1 -ylj etyl} -2-metyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-aJpyrimidin-4-ónu vzorca IThe present invention relates to a process for the preparation of 3- {2- [4- (6-fluorobenzo [d] isoxazol-3-yl) piperidin-1-yl] ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one of formula I

ktorý tná farmaceutické využitie kvôli svojim antips.ychotickým vlastnostiam.which has a pharmaceutical utility due to its antipsychotic properties.

Podobne sa vynález týka 3-(2-aminoetyl)-2-metyl-6,7,8,9 tetrah.ydro-4H-pyrido[1 ,2-ajpyrimidin-4-ónu vzorca II a zlúčenín všeobecného vzorca III.Similarly, the invention relates to 3- (2-aminoethyl) -2-methyl-6,7,8,9 tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one of Formula II and compounds of Formula III.

iand

I !I!

F !F!

II

ZFROM

CII) CIII) kde znamená Y a Z rovnaké alebo navzájom odlišné uvolňované skupiny, ako napríklad atóm halogénu alebo alkylovú skupinu alebo arylsulfonyloxyskupinu. Obidve tieto skupiny sú medziproduktami, používanými pri spôsobe podlá vynálezu.CII) CIII) wherein Y and Z are the same or different released groups, such as a halogen atom or an alkyl group or an arylsulfonyloxy group. Both of these groups are intermediates used in the process of the invention.

Zlúčeniny vzorca II a všeobecného vzorca III súčasne so svojimi prekurzormi nie sú známe zo stavu techniky.Compounds of formula II and formula III together with their precursors are not known in the art.

Doterajší stav technikyBACKGROUND OF THE INVENTION

Európsky patentový spis číslo EP 196123 popisuje štyri rôzne spôsoby prípravy 3-(2-[4-(6-fluórbenzo [d] izoxazol-3-yl)·' piperidin-1-yl]etyl} -2-metyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a] pyrimidin-4-ónu. Tri z týchto spôsobov sú založené na vytváraní systému 2-metyl-6,7,8,9-tetrahydro-4H-pyrido 1.1 ,2-a]pyrimidin-4-ónu rôznymi kondenzačnými a cyklizačnými procesmi. Štvrtý spôsob je založený na K-alkylácii 6-fluór-3-(4-piperidinyl)benzo[d]izoxazolu napríklad 3-(2-chlóretyl)-2-metyl6,7,8,9-tetrahydro-4H-pyrido [1,2-a]pyrimidin-4-ónom s rôznymi uvoíňovanými skupinami.EP 196123 describes four different methods of preparing 3- (2- [4- (6-fluorobenzo [d] isoxazol-3-yl) piperidin-1-yl] ethyl} -2-methyl-6,7 8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one Three of these methods are based on the formation of a 2-methyl-6,7,8,9-tetrahydro-4H-pyrido 1.1 system The fourth method is based on the K -alkylation of 6-fluoro-3- (4-piperidinyl) benzo [d] isoxazole, for example, 3- (2-chloroethyl) -2-pyrimidin-4-one. methyl 6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one with various released groups.

Španielske patentové spisy Číslo 2006888 a 2006889 popisujú spôsob založený na rôznych typoch konečnej cyklizácie izoxazolového kruhu.Spanish Patent Nos. 2006888 and 2006889 disclose a method based on various types of final cyclization of the isoxazole ring.

Konštrukcia N-alkylpiperidínov alebo n-arylpiperidínov, na ktorých je založený spôsob podlá vynálezu, je popísaná v chemickej literatúre reakciou 1,5-dihalogénpentánov s primárnymi amínmi /J. von Sraun, Chem, Ber. 37, 3210, 1904: 39, 4351, 1906: 40, 3914 a 3930, 1907; 42, 2048 a 2052, 1909/, aj reakciou 1-5-bis-alkylsulfonyloxypentánov alebo 1-5-bisarylsulfonyloxypentánov s primárnymi amínmi /K. Reynolds, J. Amer. Chem. Soc. 72, str. 1597, 1950/.The construction of the N-alkylpiperidines or n-arylpiperidines on which the process according to the invention is based is described in the chemical literature by reaction of 1,5-dihalopentanes with primary amines (J). von Sraun, Chem., Ber. 37, 3210, 1904: 39, 4351, 1906: 40, 3914, and 3930, 1907; 42, 2048 and 2052, 1909), also by reacting 1-5-bis-alkylsulfonyloxypentanes or 1-5-bisarylsulfonyloxypentanes with primary amines (K). Reynolds, J. Amer. Chem. Soc. 72, p. 1597, 1950].

Podstata vynálezuSUMMARY OF THE INVENTION

Spôsob prípravy 3-{2-[4-(6-fluórbenzo[d]izoxazol-3-yl] piperidin-1-yl]etyl}-2-metyl-6,7,8,9-tetrahydro-4H-pyrido[l ,2-a] pyrimidin-4-ónu vzorca IProcess for preparing 3- {2- [4- (6-fluorobenzo [d] isoxazol-3-yl] piperidin-1-yl] ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [ 1,2-a] pyrimidin-4-one of formula I

spočíva podlá vynálezu v tom, že sa necháva reagovať 3-(2-ami noetyl) -2-metyl-6,7,8,9-tetrahydro-4H-pyrido [i ,2-a]pyrimidin4-ón vzorca II so zlúčeninou všeobecného vzorca IIIAccording to the invention, 3- (2-aminoethyl) -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one is reacted with a compound of formula II of formula III

kde znamená Y a Z rovnaké alebo navzájom odlišné uvolňované skupiny, ako napríklad atóm halogénu alebo alkylovú skupinu alebo arylsulfonyloxyskupinu v prítomnosti rozpúšťadla a zásady.wherein Y and Z are the same or different leaving groups, such as a halogen atom or an alkyl or arylsulfonyloxy group, in the presence of a solvent and a base.

Reakcia sa uskutočňuje podlá nasledujúcej reakčnej schémyThe reaction is carried out according to the following reaction scheme

Reakcia sa uskutočňuje v polárnom rozpúšťadle, ako je napríklad alkohol s nízkou molekulovou hmotnosťou, napríklad metanol, etanol, izoprop.ylalkohol alebo n-butanol, s výhodou “ v etanole, alebo v polárnom aprótnom rozpúšťadle, ako je napríklad acetonitril, Ν,Ν-dimetylformamid alebo N-metylpyrolidón, s výhodou v acetonitrile, v prítomnosti organickej zásady, ako je napríklad trietylamín alebo v prítomnosti anorganickej zásady, ako je napríklad alkalický hydroxid, uhličitan alebo hydrogenuhličitan, pri teplote 40 až 120°C, s výhodou približne 80°C. Získaný produkt vzorca I sa izoluje známymi spôsobmi sa čistí sa prekryštalizovaním.The reaction is carried out in a polar solvent such as a low molecular weight alcohol such as methanol, ethanol, isopropanol or n-butanol, preferably "ethanol" or in a polar aprotic solvent such as acetonitrile, Ν, Ν- dimethylformamide or N-methylpyrrolidone, preferably in acetonitrile, in the presence of an organic base such as triethylamine or in the presence of an inorganic base such as an alkali hydroxide, carbonate or bicarbonate at a temperature of 40 to 120 ° C, preferably about 80 ° C . The product of formula I obtained is isolated by known methods and purified by recrystallization.

Zlúčeniny vzorca II a všeobecného vzorca III, potrebné na uskutočňovanie spôsobu podlá vynálezu, nie sú doteraz z literatúry známe a vynález sa ich tiež týka.The compounds of formula (II) and formula (III) required for carrying out the process according to the invention are not known from the literature and the invention also relates to them.

3-(2-Aminoetyl)-2-metyl-6,7,8,9-tetrahydro-4H-pyrido- \ [1 ,2-a] pyrimidin-4-ón vzorca II sa môže pripravovať podía nasledujúcej .reakčnej schémy:3- (2-Aminoethyl) -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one of formula II can be prepared according to the following reaction scheme:

Reakcia vedúca k nahradeniu atómu chlóru v 3-(2-chlóretyl) -2-metyl-ó,7,8,9-tetrahydro-4H-pyrido{j ,2-a] pyrimidin4-ónu vzorca IV /japonský patentový spis číslo JP 52005797; J. Fujiíta, Ann. Rep. Sankyo Res. Lab. 29, str. 75 až 97, 1977/ dibenzylamínom na získanie 3-(2-dibenzylaminoetyl)-2metyl-6,7,8,9-tetrahydro-4H-pyrido fl ,2-aJ pyrimidin-4-ónu vzorca V sa uskutočňuje vo vhodnom rozpúšťadle, napríklad v acetonitrile, za prítomnosti anorganickej zásady, ako je napríklad alkalický hydroxid, uhličitan alebo hydrogenuhličitan, alebo v prítomnosti organickej zásady, ako je napríklad trieiyiamín, pri teplote 50 až 100°C, s výhodou 70 až 90°C.Reaction to replace the chlorine atom in 3- (2-chloroethyl) -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one of formula IV / Japanese Patent Specification JP 52005797; J. Fujita, Ann. Rep. Sankyo Res. Lab. 29, p. 75-97, 1977) with dibenzylamine to give 3- (2-dibenzylaminoethyl) -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one of formula V is carried out in a suitable solvent, for example in acetonitrile, in the presence of an inorganic base such as an alkali hydroxide, carbonate or bicarbonate, or in the presence of an organic base such as triethylamine at a temperature of 50 to 100 ° C, preferably 70 to 90 ° C.

x, ·x, ·

Prídavné sa do reakčnej zmesi môže pridával ako katalyzátor jodiď alkalického kovu.In addition, an alkali metal iodide may be added to the reaction mixture as a catalyst.

Hydrogenácia 3-/2-dibenzylaminoetyl/-2-metyl-6,7,8,9-tetrahydro-4H-pyrido[l,2-a] pyrimidin-4-ónu vzorca V na 3-/2-aminoetyl/-2-metyl-6,7,8,9-tetrahydro-4H-pyrido[Ί,2-a] pyrimidin4-ón vzorca II sa uskutočňuje v inertnom rozpúšťadle, ako je napríklad metanol, etanol, izopropylalkohol alebo v zmesi týchto alkoholov s vodou v rôznych pomeroch, pri teplote 20 až 60°C, s výhodou 45 až 55°C a pri tlaku 0,1 až 2 MPa, s výhodou pri tlaku mierne vyššom ako je tlak okolia, v prítomnosti paládia na uhlí ako katalyzátora v hmotnostnom množstve 5 až 15 % vzhladom na hmotnosť východiskovej látky vzorca V. Zlúčeniny vzorca V a II sa izolujú spôsobmi známymi samými o sebe a nevyžadujú následné čistenie.Hydrogenation of 3- (2-dibenzylaminoethyl) -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one of formula V to 3- (2-aminoethyl) -2 -methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one of formula II is carried out in an inert solvent such as methanol, ethanol, isopropyl alcohol or a mixture of these alcohols with water in in various proportions, at a temperature of 20 to 60 ° C, preferably 45 to 55 ° C and at a pressure of from 1 to 2 MPa, preferably at a pressure slightly higher than ambient pressure, in the presence of 5% by weight of palladium on carbon catalyst up to 15% based on the weight of the starting material of formula V. The compounds of formulas V and II are isolated by methods known per se and do not require subsequent purification.

Zlúčeniny všeobecného vzorca III sa môžu získať pSťstupňovým spôsobom.Compounds of formula (III) may be obtained in a five-step process.

Necháva sa reagovať 4-tetrahydropyranokarbonyl vzorca VI /J. Gibson, J. Chem. Soc., str. 2525, 1930/ a 1,3-difluórbenzén vzorca VII v prítomnosti bezvodého chloridu hlinitého, čím sa získa Friedelovo-Craftsovo alkylaČné činidlo /2,4-difluorfenyl/tetrahydropyrán-4-yl) raetenón vzorca VIII, buč vo vhodnom rozpúšťadle, ako je napríklad dichlórmetán alebo 1,2— dichlóretán alebo s nadbytkom samotného 1,3-difluórbenzénu, pôsobiaceho ako rozpúšťadlo. Reakcia sa uskutočňuje pri teplote 40 až 85°C, s výhodou pri teplote približne 80°C. Produkt sa iizoluje spôsobom známym samým o sebe a čistí sa prekry stal i zovaní m.The 4-tetrahydropyranocarbonyl of formula VI / J is reacted. Gibson, J. Chem. Soc., P. 2525, 1930) and 1,3-difluorobenzene of formula VII in the presence of anhydrous aluminum chloride to give the Friedel-Crafts alkylating agent (2,4-difluorophenyl) tetrahydropyran-4-yl) methanone of formula VIII, either in a suitable solvent such as for example dichloromethane or 1,2-dichloroethane or with an excess of 1,3-difluorobenzene alone acting as solvent. The reaction is carried out at a temperature of 40 to 85 ° C, preferably at about 80 ° C. The product is isolated in a manner known per se and purified by recrystallization.

Oxím sa získa zo zlúčeniny vzorca VIII reakciou zlúčeniny vzorca VIII s hydroxylamínhydrochloridom spôsobmi známymi samými o sebe /napríklad pódia Advanced Orgánic Chemistry,The oxime is obtained from a compound of formula VIII by reacting a compound of formula VIII with hydroxylamine hydrochloride by methods known per se (e.g., Advanced Organic Chemistry),

J. March, 4. vydanie, str. 406/. Zmes /75 : 25/ sin a anti izomérov (2,4-difluórfeny.l) tetr.ahydropyrári-4-yl.)metahónóx:£-l.-. mu vzorca IX sa izoluje spôsobmi známymi samými o sebe a môže sa bud priamo používaf v nasledujúcom reakčnom stupni ; bez predbežného oddeíovania izomérov, alebo sa väčšina sin oxímu môže izolovaí stĺpcovou chromatografiou na silikagéle.J. March, 4th edition, p. 406 /. A mixture of (75: 25) sin and anti isomers (2,4-difluorophenyl) tetrahydropyria-4-yl) methoxone: .delta. The compound of formula IX is isolated by methods known per se and can either be used directly in the next reaction step; without pre-separation of the isomers, or most of the sin oxime can be isolated by column chromatography on silica gel.

Postupuje sa podlá nasledujúcej reakčnej schémy:The procedure is as follows:

HO x iHO x i

kde Y, Z sú rovnaké alebo navzájom odlišné a znamenajú atóm chlóru, brómu alebo jódu, skupinu CH^-SO^- alebo p-ch3c6h4so3.wherein Y, Z are the same or different from each other and represent a chlorine, bromine or iodine atom, a CH 2 -SO 4 - or p-ch 3 c 6 h 4 s 3 group .

Cyklizácia zmesi oxímov vzorca IX alebo príslušného sinizoméru na 6-fluór-3-(tetrahydropyrán-4-yl)benzoCd]izoxazol vzorca X sa uskutočňuje vo vhodnom rozpúšťadle, ako je napríklad metanol a etanol, v prítomnosti zásady,ako je napríklad hydroxid, uhličitan alebo hydrogenuhličitan alkalického kovu, alebo v tetrahydrofuráne alebo v dioxáne a v prítomnosti hyd.roxidu alebo alkoxidu alkalického kovu. Reakcia sa uskutočňuje pri teplote 50 až 100°C, s výhodou pri teplote varu reakčnej zmesi. Produkt vzorca X sa izoluje spôsobmi známymi samými o sebe. Musí sa oddeíovaí od nereaktívneho izoméru povod ného oxímu vzorca IX stĺpcovou chromatografiou na silikagéle, ak sa ako východiskóvá látka použila zmes oxímov.The cyclization of a mixture of oximes of formula IX or the corresponding sinisomer to 6-fluoro-3- (tetrahydropyran-4-yl) benzo [d] isoxazole of formula X is carried out in a suitable solvent such as methanol and ethanol in the presence of a base such as hydroxide, carbonate or an alkali metal bicarbonate, or tetrahydrofuran or dioxane and in the presence of an alkali metal hydroxide or alkoxide. The reaction is carried out at a temperature of 50 to 100 ° C, preferably at the boiling point of the reaction mixture. The product of formula X is isolated by methods known per se. It must be separated from the non-reactive isomer of the native oxime of formula IX by column chromatography on silica gel if a mixture of oximes is used as starting material.

Otváranie tetrahydropyranolového éteru na 6-fluór-3(tetrahydropyrán-4-yí)benzo[cQizoxazol vzorca X sa uskutočňuje za použitia rôznych činidiel podlá povahy skupín symbolu Y a Z, žiadúcich v zlúčenine všeobecného vzorca III. Môže sa použií napríklad bromid fosforitý v prítomnosti kyseliny bromovodíkovej alebo kyseliny fosforečnej pri teplote 140°C /P. Volynskii, Izv. Akad. Náuk SSSP Ser. Chim. 11, str. 2528, 1979, C. A. 92, 1 28341, 1980/ za priameho'získania zlúčeniny všeobecného vzorca III /Y = Z = Br/. Spracovaním zlúčeniny vzorca X bu3 acetylbromidom v prítomnosti chloridu zino'čnatého ako katalyzátora /V. N. Odinov, Chim. Prir. Soedin. 2, str. 272 až 276, 1989/ alebo bezvodým bromičom horečnatým v acetanhydride /D. J. Goldsmith, J. Org. Chem. 40, str. 3571 , 1975/ a následným zmydelnením získaného brómacetátu uhličitanom draselným v metanole za teploty okolia sa získa brómalkohol všeobecného vzorca XI /Y = Br/. Podobne sa získa zlúčenina všeobecného vzorca XI /Y = 1/ spracovaním zlúčeniny všeo- .. becného vzorca X acetyljodidom v acetonitrile za teploty spätného toku reakčnej zmesi /A, Oku, Tetrahedron Lett. 23, str. 682, 1982/ a zmydelnením jódacetátu získaného ako medziprodukt.The opening of the tetrahydropyranol ether to the 6-fluoro-3 (tetrahydropyran-4-yl) benzo [c] isoxazole of formula X is carried out using various reagents according to the nature of the groups Y and Z desired in the compound of formula III. For example, phosphorus tribromide in the presence of hydrobromic acid or phosphoric acid at 140 ° C / P can be used. Volynskii, Izv. Akad. SSSP Teaching Ser. Chim. 11, p. 2528, 1979, C.A. 92, 1234341 (1980) (directly yielding a compound of formula III (Y = Z = Br)). Treatment of the compound of formula X with either acetyl bromide in the presence of zinc chloride as catalyst (V). N. Odinov, Chim. Acc. Soedin. 2, p. 272-276, 1989] or anhydrous magnesium bromide in acetic anhydride (D). J. Goldsmith, J. Org. Chem. 40, p. 3571, 1975] and subsequent saponification of the obtained bromoacetate with potassium carbonate in methanol at ambient temperature affords the bromo alcohol of formula XI (Y = Br). Similarly, a compound of formula XI (Y = 1) is obtained by treating the compound of formula X with acetyl iodide in acetonitrile at the reflux temperature of the reaction mixture (A, Oku, Tetrahedron Lett). 23, p. 682, 1982) and by saponification of the iodoacetate obtained as an intermediate.

Halogénalkoholy všeobecného vzorca XI sa premieňajú na dihalogénované produkty všeobecného vzorca III spracovaním klasickými alkoholhalogéndehydratačnými činidlami, ako je napríklad tionylchlorid, chlorid fosforitý a chlorid fosforečný) trichlórid-oxid fosforečný alebo bromid fosforitý /napr. Advanced Organic Chemistry, J. March, /.vydanie, str. 433/. Podobne spracovaním hologénalkoholov všeobecného vzorca XI alk.ylhalogenidom alebo arylsulfonylovou zlúčeninou, napríklad mpténsulfonylchloridom alebo p-toluénsulfonylchloridom sa získa príslušný halogénmetánsulfonát alebo halogén-p-toluénsulfo· nát všeobecného vzorca III.The haloalcohols of formula (XI) are converted to the dihalogenated products of formula (III) by treatment with classical alcohol halide dehydrating agents such as thionyl chloride, phosphorus trichloride and phosphorus trichloride) trichloride-phosphorus trioxide or phosphorus tribromide (e.g. Advanced Organic Chemistry, J. March, / Publication, p. 433 /. Similarly, treatment of the haloalcohols of formula XI with an alkyl halide or an arylsulfonyl compound, for example mptenesulfonyl chloride or p-toluenesulfonyl chloride, affords the corresponding halomethanesulfonate or halo-p-toluenesulfonate III.

Príklady uskutočnenia vynálezuDETAILED DESCRIPTION OF THE INVENTION

Príklad 1Example 1

3-( 2-Dibenzylaminoetyl)-2-metyl-6,7,8,9-tetrahydro-4H-pyridoD ,2-a]pyrimidin-4-ón /zlúčenina vzorca V/ g /0,1666 mol/ hydrogenuhličitanu sodného a 24 g /0,1218 mol/ dibenzylamínu sa pridá do roztoku 25 g /0,1104 mol/ 3-(2-chlóretyl)-2-metyl-6,7,8,9-tetrahydro-4H-pyrido[l,2-aJ pyrimidin-4-ónu v 125 ml acetonitrilu. Reakčná zmes sa varí pod spfitným chladičom 16 hodín, ochladí sa na teplotu 5°C a pretrepáva sa 30 minút pri teplote 5°C. Pevná látka sa suspenduje v 125 ml vody a zmes sa zohrievaním, udržiava na teplote 60°C za pretrepávania jednu hodinu. Suspenzia sa nechá o- _ chladil na teplotu okolia a pretrepáva sa 30 minút. Pevná látka sa odfiltruje, odsaje a vysuší sa vo vákuu pri teplote 40°C, čím sa získa 35,7 g 3-(2-dibenzylaminoetyl)-2-metyl6,7,8,9-tetrahydro-4H-pyrido-[l,2-aJpyrimidin-4-ónu vo forme bielej pevnej látky s výiažkom 84 %·3- (2-Dibenzylaminoethyl) -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one (V) compound (g) (0.1666 mol) sodium bicarbonate; and 24 g (0.1218 mol) of dibenzylamine is added to a solution of 25 g (0.1104 mol) of 3- (2-chloroethyl) -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one in 125 ml acetonitrile. The reaction mixture was refluxed for 16 hours, cooled to 5 ° C and shaken for 30 minutes at 5 ° C. The solid was suspended in 125 mL of water and the mixture was heated to 60 ° C with shaking for one hour. The suspension was allowed to o _ cooled to room temperature and shaken for 30 minutes. The solid is filtered off, suctioned off and dried under vacuum at 40 ° C to give 35.7 g of 3- (2-dibenzylaminoethyl) -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1]. , 2-apyrimidin-4-one as a white solid with a yield of 84% ·

Teplota topenia 110 až 111°C.Mp 110-111 ° C.

IR /KBr/ cm1 : 3020, 2980-2800, 1655, 1588, 1533, 1444, 1188, 744, 694.IR (KBr / cm < -1 > ) : 3020, 2980-2800, 1655, 1588, 1533, 1444, 1188, 744, 694.

RNM /CDCl^/, £/ppm/: 7,40-7,15 /sc, 10H; aromat./RNM (CDCl 3), δ (ppm): 7.40-7.15 (sc, 10H); aromat./

3,80 /t J=6, 2H; CH2 pyridopyrimidón/3.80 / t J = 6.2, 2H; CH 2 pyridopyrimidone /

3,65 /s, 4H; CH2 benzyl/3.65 / s, 4H; CH 2 benzyl /

2,85 /t J=6, 2H; CH2 pyridopyrimidón/2.85 / t J = 6.2, 2H; CH 2 pyridopyrimidone /

2,70 ./sc, 2E; CH2 etylén/2.70 ./sc, 2E; CH 2 ethylene /

2,60 /sc, 2H; CPÍ2 etylén/2.60 / sc, 2H; CPI 2 ethylene /

2,10 /s, 3H; ChT3/2.10 / s, 3H; Ch T 3 /

1,90 /sc, 4K; CH2 pyridopyrimidón/1.90 / sc, 4K; CH 2 pyridopyrimidone /

Elementárna analýza pre C25H29N3° /molekulová hmotnosi: 387,53/.Elemental analysis for C 25 H 29 N 3 ° (MW: 387.53).

vypočítané /%/: C 77,49 K 7,54 N 10,87 nájdené./£/: C 77,36 K 7,59 N 10,77calculated (%): C 77.49 K 7.54 N 10.87 found: C 77.36 K 7.59 N 10.77

Príklad 2Example 2

3-(2-Aminoetyl) -2-metyl-6,7 , S,9-tetrahydro-4K-p,yrido- [1 ,2-aJ pyrimidin-4-ón /zlúčenina vzorca II/3- (2-Aminoethyl) -2-methyl-6,7,5,9-tetrahydro-4K-ppyrido [1,2-a] pyrimidin-4-one (compound of formula II)

Do suspenzie 20 g /0,0517 mol/ 3-(2-dibenzylaminoetyl)-2metyl-6,7,8,9-tetrahydro-4K-pyrido-[l,2-ajpyrimidin-4-ónu v 100 ml etanolu sa vnesú 2 g 10% paládia na uhlí s obsahom vlhkosti 50 %. Zmes sa hydrogenuje pri teplote 45 až 50 C až do spotrebovania 2,7 1 vodíka. Zmes sa nechá ochladli na teplotu okolia, katalyzátor sa odfiltruje cez decalitr a rozpúšťadlo sa odstráni vo vákuu, čím sa získa olejovitý zvyšok, ' ktorý sa prekryštaližuje a spracuje heptánom. Produkt sa vysuší vo vákuu pri teplote okolia za získania 9,3 g 3-(2-amino-— etyl)-2 -metyl-6,7,8,9-tetrahydro-4H-pyrido- (j ,2-aJpyrimidin4-ónu v.o forme bielej pevnej látky s výťažkom 88 .To a suspension of 20 g (0.0517 mol) of 3- (2-dibenzylaminoethyl) -2-methyl-6,7,8,9-tetrahydro-4K-pyrido [1,2-a] pyrimidin-4-one in 100 ml of ethanol is added 2 g of 10% palladium on carbon with a moisture content of 50%. The mixture is hydrogenated at 45-50 ° C until 2.7 liters of hydrogen are consumed. The mixture was allowed to cool to ambient temperature, the catalyst was filtered off over decalitr, and the solvent was removed in vacuo to give an oily residue which was recrystallized and treated with heptane. The product is dried under vacuum at ambient temperature to give 9.3 g of 3- (2-amino-ethyl) -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one; in the form of a white solid with a yield of.

Teplota topenia 126°C.Melting point 126 ° C.

IR /KBr/ cm1 : 3322, 2944, 1655, 1588, 1527, 1322, 1194,IR / KBr / cm < -1 >: 3322, 2944, 1655, 1588, 1527, 1322, 1194,

RNM /CDCl^/, <T/ppm/ : 3,90 /t J=6; CH2 pyridopyrimidón/RNM (CDCl 3), δ T (ppm): 3.90 (t J = 6); CH 2 pyridopyrimidone /

3,85 /t J=7; CH^ pyridopyrimidón a CH2 etylén/3.85 / t J = 7; CH 2 pyridopyrimidone and CH 2 ethylene /

2.70 /t J=7; 2H; CH2 etylén/2.70 / t J = 7; 2H; CH 2 ethylene /

2,30 /s, 3H; CHy2.30 / s, 3H; CHy

1,90 /sc, 4H; CH2 pyridopyrimidón/1.90 / sc, 4H; CH 2 pyridopyrimidone /

1.70 /sa, 2H; NH2 deut./1.70 / s, 2H; NH 2 deut./

Elementárna analýza pre /molekulová hmotnosť :Elemental analysis for / molecular weight:

207,28/.207,28 /.

vypočítané /%/: C 63,74 H 8,27 N 20,27 nájdené /%/: C 63,69 H 8,26 N 20,35calc. /% /: C 63.74 H 8.27 N 20.27 found /% /: C 63.69 H 8.26 N 20.35

Príklad 3 (2,4-Difluórfenyl)-(tetrahydropyrán-4-yl) metanón /zlúčenina vzorca VIII/Example 3 (2,4-Difluorophenyl) - (tetrahydropyran-4-yl) methanone (compound of formula VIII)

34,1 g /0,229 mol/ 4-tetrahydropyránkarbonylchloridu sa po kvapkách pridáva do pretrepávanej suspenzie 61,3 g /0,460 mol/ bezvodého chloridu hlinitého v 113 ml 1,3-difluórbenzénu. Zmes sa varí pod spätným chladičom 20 hodín, nechá sa vychladnú? na teplotu miestnosti a reakčná zmes sa vleje do zmesi 500 g íadu a 50 ml koncentrovanej kyseliny chlorovodíkovej, Zmes sa extrahuje trikrát vždy 200 ml dichlórmetánu. Organické fázy sa spoja, premyjú sa nasýteným vodným roztokom soli a vysušia sa bezvodým síranom sodným. Rozpúšťadlo sa odparí vo vákuu, čím sa získa sol, ktorá vykryštalizuje. Sol sa prekryštaližuje z heptánu, čím sa získa 41,1 g (2,4-difluorfenyl) - (tetrahydropyrán-4-yl) metanónu vo forme bielej pevnej látky s výťažkom 80 %·34.1 g (0.229 mol) of 4-tetrahydropyrancarbonyl chloride is added dropwise to a shaken suspension of 61.3 g (0.460 mol) of anhydrous aluminum chloride in 113 ml of 1,3-difluorobenzene. The mixture was refluxed for 20 hours, allowed to cool? The reaction mixture is poured into a mixture of 500 g of ice and 50 ml of concentrated hydrochloric acid. The mixture is extracted three times with 200 ml of dichloromethane each time. The organic phases are combined, washed with a saturated aqueous salt solution and dried over anhydrous sodium sulfate. The solvent was evaporated in vacuo to give a salt which crystallized. The salt was recrystallized from heptane to give 41.1 g of (2,4-difluorophenyl) - (tetrahydropyran-4-yl) methanone as a white solid in 80% yield.

Teplota topenia 50 až 51°C.Mp 50-51 ° C.

IR /KBr/ cm' : 3054, 2964, 2845, 1680, 1605, 1485, 1421 ,IR (KBr / cm &lt; -1 &gt;): 3054, 2964, 2845, 1680, 1605, 1485, 1421,

1093.1,093th

RNM /CDCl^/ áVppm/ : 7,85 /dód, 1H; aromat./RNM (CDCl 3) (δ vpm): 7.85 (dod, 1H); aromat./

6,80 /m, 2H; aromat./6.80 / m, 2H; aromat./

4,05 /dt, 2H, H-eq^-O-THP/4.05 (dt, 2H, H-eq -O-THP)

3,50 /m, 2K; H-ax-Ä-O-TKP/3.50 / m, 2K; Ax-H-R-H-TKP /

3,30 /m, 1H; CH-C=O/3.30 / m, 1 H; CH-C-O /

1,85 /sc, 4H; THP/1.85 / sc, 4H; THP /

Elementárna., analýza pre ^-)2^12^2^2 /mo^e^ulov^ hmotnosť: 226,22/ vypočítané /%/ : C 63,71 H 5,35 N 16,80 nájdené /%/ : C 63,65 K 5,38 N 16,75·Anal., Calcd for ^ -) 2 ^ 12 ^ 2 ^ 2 / mo ^ e ^ s ^ ul weight: 226.22 / Calculated /% /: C 63.71 H 5.35 N 16.80 Found /% /: C 63.65 K 5.38 N 16.75 ·

Príklad 4 (2,4-dif luórf enyl) -(t e trahydropyran-4-yl) met anpnqxím /zlúčenina vzorca· IX/EXAMPLE 4 (2,4-Difluorophenyl) - (tetrahydro-pyran-4-yl) -methoxyxime (compound of formula · IX)

Do roztoku 31 g /0,137 mol/ (2,4-difluórfenyl)-(tetrahydro pyran-4-yl)..metanónu v 1 00 ml etanolu sa-pridá 10 g /0,144 mol/ hydroxylamínhydrochloridu, rozpusteného v 50 ml vody a 20 ml /0,147 mol/ trihydrátu octanu sodného. Získaný roztok sa varí pod spätným chladičom 10 hodín. Zmes sa ochladí a etanol sa odparí vo vákuu. Pridá sa 100 ml vody a získaná suspenzia sa :ochladí na teplotu 5°C a pevná látka sa odfiltruje, premyje sa íadovou vodou a vysuší pri teplote 40°C. Získa sa 32£4 g (2,4-difluórfenyl)-(tetrahydropyrán-4-yl)metanónoxímu vo forme bielej pevnej látky, ktorá je- : .zmesou /3 i 1/ sin/anti oxímov s výťažkom 93 ľ,To a solution of 31 g (0.137 mol) of (2,4-difluorophenyl) - (tetrahydro-pyran-4-yl) -methanone in 100 ml of ethanol is added 10 g (0.144 mol) of hydroxylamine hydrochloride dissolved in 50 ml of water and 20 ml. ml (0.147 mol) of sodium acetate trihydrate. The resulting solution was refluxed for 10 hours. The mixture was cooled and the ethanol was evaporated in vacuo. 100 ml of water are added and the suspension obtained is cooled to 5 ° C and the solid is filtered off, washed with ice water and dried at 40 ° C. 32 £ give 4 g (2,4-difluorophenyl) - (tetrahydropyran-4-yl) methanone oxime as a white solid, which is-: .zmesou / 3 and 1 / sin / anti oxime with a yield of 93 L,

Žiadaný sin oxím sa oddelí od svojich izomérov chromatografiou na silikagéle za použitia systému činidla heptán/ etylacetát /7 : 3/ ako elučného činidle.The desired sin oxime was separated from its isomers by chromatography on silica gel using heptane / ethyl acetate (7: 3) as eluent.

Teplota topenia 115 až 116°C.Mp 115-116 ° C.

IE /KBr/ cm1: 3323, 2936, 2850, 1617, 1505, 1421, 1110, 969, 845.IE / KBr / cm 1 : 3323, 2936, 2850, 1617, 1505, 1421, 1110, 969, 845.

ENM /CDCl-j/, T/ppm/: 8,10 /s, 1H; N-OH, deut./ENM (CDCl 3), δ (ppm): 8.10 (s, 1H); N-OH, deut./

7,15 /ddd, 1H; aromat./7.15 / ddd, 1H; aromat./

6,95 /m, 2H; aromat./6.95 / m, 2H; aromat./

4,00 /dt, 2H; K-eq-«-O-TKP/4.00 / dt, 2H; K-eq - '- O-TKP /

3,40 3.40 /m, / M 2H; 2H; H-ax-<*-0-THP/ H-ax - <* - 0-THP / 2,70 2.70 /m, / M 1H; 1 H; CH-C=O/ CH-C-O / 1 ,70 1, 70 /m, / M 4H; 4H; THP/ THP / Elementárna Elementary analýza analysis pre C. away. 13N0 13 N0 /molekulová hmotnosf: / molecular weight: 241,22/ 241.22 / vypočítané j calculated j /%/: C (%): C 59,56 59.56 H H 5, 5 42 F 13,24> 42 F 13.24> N 5,80 N, 5.80 nájdené /%/ found /% / C C 59,61 59.61 H H 55, 55. 48 F 13,19 48 F 13.19 N 5,82 N, 5.82

Príklad 5Example 5

6-Fluór-3-(tetrah,ydropyrán-4-yl) benzoCdJ izoxazol /zlúčenina vzorca X/6-Fluoro-3- (tetrahydro-ydropyran-4-yl) benzo [d] isoxazole (compound of formula X)

Do roztoku 3 g /0,0454 mol/ hydroxidu draselného, 85%, v 100 ml etanolu sa pridá 10 g /0,0415 mol/ sin-oxímu (2,4difluórf enyl}- (tetrahydropyran-4-yl) metanónu. Zmes sa varí 1 hodinu pod spätným chladičom, ochladí sa na teplotu okolia a rozpúšfadlo sa dofsucha odparí. Pridá sa 50 ml vody. Získaná suspenzia sa pretrepáva 15 minút, pevná látka sa odfiltruje a dôkladne premyje vodou. Získaná biela pevná látka sa suší vo vákuu pri teplote 40°C, čím sa získa 9,0 g 6-fluor-3(tetrahydropyran-4-yl) benzofdjizoxazolu s výfažkom 98 %. Teplota topenia 86 až 87°C.To a solution of 3 g (0.0444 mol) of potassium hydroxide, 85%, in 100 ml of ethanol, 10 g (0.0415 mol) of sin-oxime (2,4-difluorophenyl} - (tetrahydropyran-4-yl) methanone) was added. The reaction mixture was refluxed for 1 hour, cooled to ambient temperature and the solvent was evaporated to dryness, water (50 ml) was added, the suspension was shaken for 15 minutes, the solid was filtered off and washed thoroughly with water. 40 ° C to give 9.0 g of 6-fluoro-3- (tetrahydropyran-4-yl) benzofedisoxazole in 98% yield, mp 86-87 ° C.

IR /KBr/ cm1: 2926, 2858, 1612, 1498, 1240, 1123, 840.IR (KBr / cm &lt; -1 &gt; ) : 2926, 2858, 1612, 1498, 1240, 1123, 840.

ENM /CDCl^/í/ppm/: 7,65 /dd, 1H; aromat./ENM (CDCl3) (ppm): 7.65 (dd, 1H); aromat./

7,25 /dd, 1H; aromat./ ··7.25 / dd, 1 H; aromat./ ··

7,05 /ddd, 1H; aromat./7.05 / ddd, 1H; aromat./

4,10 /dt, 2H; H-eq-ck-O-THP/ 3,60 /ddd, 2H; H-ax-c<-O-TKP/4.10 / dt, 2H; H-eq-ck-O-THP (3.60) ddd, 2H; Ax-H-C <-O-TKP /

3,35 /m, 1H; 3.35 / m, 1 H; CH-C=N/ CH-C-N / 2,10 /m, 4K; 2.10 / m, 4K; THP/ THP / Elementárna analýza pre £H Elemental analysis for [delta] H . pFNOp /molekulová . pFNOp / molecular hmotnosť; weight; 221,23/ 221.23 / vypočítané;/%/: C 65,15 K (%): C 65.15 K 8,59 F 8.59 F 8,59 8.59 N N 6,33 6.33 nájdené /%/: C 65,22 H found (%): C 65.22 H 8,52 F 8.52 F 8,65 8.65 N N 6,29. 6.29.

Príklad 6Example 6

3- f6-Fluórbenzo[dJ izoxazol-3-yl? -5-jódpentán-1- ol- /zlúčenina vzorca XI, X = 1/3- [6-Fluorobenzo [d] isoxazol-3-yl? -5-iodopentan-1-ol- (compound of formula XI, X = 1)

Do roztoku 3,4 g /0,0154 mol/ 6-fluór-3-(tetrahydropyran4- y1) benzo[djizoxazolu v 20 ml suchého acetonitrilu sa pridá postupne 8,147 g /0,054 mol/ jodidu sodného a 3,3 ml /0,0462 mol/ acetylchloridu. Zmes sa varí v prostredí suchého dusíka 8 hodín pod spätným chladičom. Reakčná zmes sa nechá ochladil na teplotu okolia a vleje sa do 20 g roztoku metahydrogensiriČitanu sodného a v 60 ml vody. Acetonitril sa odparí vo vákuu a zvyšok so extrahuje trikrát vždy 50 ml dichlórmetánu. Organické fázy sa spoja, premyjú sa 50 ml nasýteného vodného roztoku soli a vysušia sa bezvodým síranom sodným. Rozpúšťadlo sa odparí vo vákuu a olejovitý zvyšok sa rozpustí v 20 ml metanolu. Pridá sa 2,13 g /0,0154 mol/ bezvodého uhličitanu draselného a zmes sa pretrepáva pri teplote okolia 30 minút.To a solution of 3.4 g (0.0154 mol) of 6-fluoro-3- (tetrahydropyran-4-yl) benzo [d] isoxazole in 20 ml of dry acetonitrile is added successively 8.147 g (0.054 mol) of sodium iodide and 3.3 ml (0.1 ml). 0462 mol / acetyl chloride. The mixture was refluxed under dry nitrogen for 8 hours. The reaction mixture was allowed to cool to ambient temperature and poured into 20 g of sodium metabisulphite solution and 60 ml of water. The acetonitrile is evaporated off under vacuum and the residue is extracted three times with 50 ml of dichloromethane each time. The organic phases are combined, washed with 50 ml of a saturated aqueous salt solution and dried over anhydrous sodium sulfate. The solvent was evaporated in vacuo and the oily residue was dissolved in 20 ml of methanol. Anhydrous potassium carbonate (2.13 g, 0.0154 mol) was added and the mixture was shaken at ambient temperature for 30 minutes.

Pridá sa 7,8 ml 3N kyseliny chlorovodíkovej, metanol sa odparí vo vákuu a zvyšok sa rozdelí medzi 20 ml vody a 20 ml dichlórmetánu. Organická fáza sa oddelí, vysuší sa bezvodým síranom sodným, rozpúšťadlo sa odparí vo vákuu dosucha, Čím sa získa 3,54 g 3-(6-fluórbenzo[dj izoxazol-3-yl) 5-jódpentánu-l“0^ vo forme oleja /zlúčenina vzorca XI, X = 1/ s výťažkom 66 %.7.8 ml of 3N hydrochloric acid are added, the methanol is evaporated off under vacuum and the residue is partitioned between 20 ml of water and 20 ml of dichloromethane. The organic phase was separated, dried over anhydrous sodium sulfate, the solvent was evaporated in vacuo to dryness to give 3.54 g of 3- (6-fluoro-benzo [dj isoxazol-3-yl) 5-iodo-pentane-l "^ 0 as an oil (compound of formula XI, X = 1) in 66% yield.

Produkt sa môže čistiť stĺpcovou chromatografiou na silikagéle za použitia systému heptán/etylacetát ako elučnéhoThe product can be purified by silica gel column chromatography using heptane / ethyl acetate as eluent

4- 15 činidla /7 : 3/.4- 15 reagents (7: 3).

IR /KBr/ cm1: 3400, 3100, 2950, 16155 1500, 1280, 1120, 10505 960, 840, _IR / KBr / cm 1: 3400, 3100, 2950, 1615 5 1500, 1280, 1120, 1050 5960, 840 _

RMM /CDCl^/ S/ppm/: 7,75 /dd , 1H; aromat./RMM (CDCl3) (ppm): 7.75 (dd, 1H); aromat./

7,25 /sss, 1H; aromat./7.25 / sss, 1H; aromat./

7.10 /ddč, 1H; aromat./7.10 / ddc, 1H; aromat./

3,65 /sc, 3H; CH-C=N a CH2-OH/3.65 / sc, 3H; CH-C = N and CH 2 -OH /

3,15 /m, 2H; CH2-I/3.15 / m, 2H; CH 2 -I /

2,40 /m, 2H; CH2-CH2-OH/2.40 / m, 2H; CH 2 -CH 2 -OH /

2.10 /m, 2H; ChT2-CH2-I/2.10 / m, 2H; Ch T 2 -CH 2 -I /

1,70 /s, 1H; -OH, deut./1.70 / s, 1H; -OH, deut./

Elementárna analýza pre 2H^FINC>2 /molekulová hmotnosE: 349,14/ vypočítané /%/: C 41,23 H 3,75 F 5,44 I 36,35 K 4,01 nájdené /%/\ C 41,32 H 3,82 F 5,39 I 36,24 N 3,95Elemental analysis for &lt; RTI ID = 0.0 &gt; 2H-FINC2 &lt; / RTI & gt ; (molecular weight: 349.14 (calculated /%)): C 41.23 H 3.75 F 5.44 I 36.35 K 4.01 found (%) 32 H 3.82 F 5.39 I 36.24 N 3.95

Príklad 7Example 7

3- (6-flúóŕbenzo ľdjizoxazol-r3-yl) -4-izopentylmetánsulfonát /zlúčenine všeobecného vzorca III, X = 1, Y = -O-SC^-CH^/3- (6-Fluorobenzo [d] isoxazol-3-yl) -4-isopentyl methanesulfonate (compound of formula III, X = 1, Y = -O-SO 2 -CH 2)

Postupne sa pridávajú 2 ml /0,0143 mol/ trietylamínu a2 ml (0.0143 mol) of triethylamine a are successively added

1,1 ml /0,0143 mol/ metánsulfonylchloridu v 1C ml dichlórmetánu do roztoku 3,533 g /0,01 mol/ 3-(6-fluórbenzoEd]izoxazol-3-yl)-4-jódpentán-1-olu v 20 ml suchého dichlórmetánu vopred ochladeného na teplotu 0°C. Zmes sa pretrepáva pri teplote 0 až 5°C 1 hodinu. Pridá sa 20 ml vody, kvapalina sa dekantuje a vodná fáza sa extrahuje dvakrát 20 ml dichlórmetánu. Spojené organické fázy sa premyjú postupne 20 ml 1N kyseliny chlorovodíkovej a 20 ml nasýteného vodného roztoku soli. Vysušia sa bezvodým síranom sodným a rozpúšEadlo sa odparí dofsucha, Čím sa získa 3,48 g 3-(6-fluórbenzoEd]izoxazol-3-yl)4- izopentylmetánsulŕenátu vo forme oleja s výíažkom 81 %.1.1 ml (0.0143 mol) of methanesulfonyl chloride in 1C ml of dichloromethane to a solution of 3.533 g (0.01 mol) of 3- (6-fluorobenzoEd] isoxazol-3-yl) -4-iodopentan-1-ol in 20 ml of dry of dichloromethane pre-cooled to 0 ° C. The mixture was shaken at 0-5 ° C for 1 hour. 20 ml of water are added, the liquid is decanted and the aqueous phase is extracted twice with 20 ml of dichloromethane. The combined organic phases are washed successively with 20 ml of 1N hydrochloric acid and 20 ml of saturated aqueous salt solution. It was dried over anhydrous sodium sulfate and the solvent was evaporated to dryness to give 3.48 g of 3- (6-fluorobenzo [d] isoxazol-3-yl) 4-isopentyl methanesulphenate as an oil in 81% yield.

IR (K. B r) c/n-1 . IR (K. Br) cis / n-1. 3090, 2.930, 3090, 2.930, Í615, 1350, 1175, í 1615, 1350, 1175, p Ϊ55. - Ϊ55. - 820, 820. RNN (COCls), δ RNN (COCl), δ (pprn): 7,7 5 (pprn): 7.7 5 (dd, 1K; arcistat·) (dd, 1k; arcistat ·) 7,30 7.30 (dd, 1H; aromat-) (dd, 1H; aromatic) 7,15 7.15 (ddd, 1H; aromat.) (ddd, 1H; arom.) 4,20 4.20 (m, 2H; CH2~0ä5-)(m, 2H, CH2 ~ 0 and 5) 3,60 3.60 (m, 1H; CK--C--N) (m, 1H; C-C-N) 3,15 3.15 (m, 2.H ; CH?-J) (m, 2.H; CH 2 -J) 2,95 2.95 (s, 3H; CH3-SO3-) (s, 3H; CH 3 -SO 3 -) 2,35 2.35 (sc, 4H; CH2-CH2-J a (sc, 4H; CH 2 -CH 2 -J a i CH2 i CH 2 -CK2-O3S-) -CK2-O3S-) Elementárna Elementary analýza pre analysis for C H.rPINO, /molekulová C. H. rPINO, / molecular hmotnosť mass 426,73/ 426.73 / vypočítané / calculated / %/: C 36,59 %: C, 36.59 H 3,54 F 4,45 H 3.54 F 4.45 J J 29,74 N. 29.74 N. 3,28 3.28 nájdené /%/: found /% /: S 7,51 S 7.51 C 36,62 C, 36.62 H 3,60 F 4,50 H 3.60 F 4.50 J J 29,69 N 29.69 N O QO O QO O S 7,60 S, 7.60

Príklad 8Example 8

3-{2-£4-(6-Fluórbenzo£d3izoxazol-3-yl) piperidin-1-yl|etylj2-metyl-6,7,8,9-tetrahydro-4H-pyrido [i , 2-aj pyrimidin-4-ón /zlúčenina vzorca 1/3- {2- [4- (6-Fluoro-benzo [d] isoxazol-3-yl) -piperidin-1-yl] -ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidine- 4-one (compound of formula 1)

Rozpustí sa 20 g /0,08 mol/ 3-(2-eminoetyl)-2-metyl6,'7,8,9-tetrahydro-4H-p.yrido-[i ,2-a]pyrimidin-4-ónu a 34,2 g /0,08 mol/ 2-(6-fluórbenzotdJizoxazol-3-yl)4-izopentylmetánsulfonátu v 300 ml acetonitrilu. Pridá sa 17 g /0,2 mol/ hyd rogenuhličitanu sodného a získaný produkt sa zohrievaním udržiava na teplote varu 6 hodín. Reakčná zmes sa ochladí na teplotu okolia a rozpúšťadlo sa odparí vo vákuu. Pridá sa 300 ml vody a suspenzia sa zohrievaním udržiava na teplote varu 30 minút bez pretrepávania.20 g (0.08 mol) of 3- (2-eminoethyl) -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one is dissolved and 34.2 g (0.08 mol) of 2- (6-fluorobenzothiazolazol-3-yl) 4-isopentyl methanesulfonate in 300 ml of acetonitrile. Sodium bicarbonate (17 g, 0.2 mol) was added and the product obtained was heated to reflux for 6 hours. The reaction mixture was cooled to ambient temperature and the solvent was evaporated in vacuo. 300 ml of water are added and the suspension is heated to boiling for 30 minutes without shaking.

Reakčná zmes sa ochladí na teplotu okolia, svetlo okrovo sfarbená pevná látka sa odfiltruje, premyje sa vodou aThe reaction mixture was cooled to ambient temperature, the light ocher-colored solid was filtered off, washed with water and

4· vysuší sa pri teplote 50°C. Po prekryštalizovaní z etanolu sa získa 26,3 g 3-{2-'[4-(6-fluórbenzo[dJizoxezol-3~yl)piperidin-1 -ylj etyl} 2-metyl-6,7,8,9-tetrahydro-4H-pyrido £l , 2-a] p.yrimidin-4-ónu vo forme bielej pevnej látky s výíažkom 80 %. Teplota topenia 170°C.4 · dried at 50 ° C. Recrystallization from ethanol gave 26.3 g of 3- {2 - [[4- (6-fluorobenzo [d] isoxezol-3-yl) piperidin-1-yl] ethyl} 2-methyl-6,7,8,9-tetrahydro -4H-pyrido [1,2-a] pyrimidin-4-one as a white solid in 80% yield. Melting point 170 ° C.

IR. (kúr) cm-1 : 3060, 2944 RNM (COC13), δ (pprn): 7,75IR. (cure) cm -1: 3060, 2944 RNM (COCl 3 ), δ (pprn): 7.75 , 2300, 1650, 1527, 1122. , 2300, 1650, 1527, 1122. (dd, 1H; (dd, 1 H; oromat·) · Oromo) 7,25 7.25 (dd, 1H; (dd, 1 H; aromat.) aromatic). 7,05 7.05 (ddd, 1H (ddd, 1 H ; aroidat-) ; aroidat-) 3,95 3.95 (t. 2'rí; (t. 2'ri; CH 2 pyrldopyrimidin) CH 2 pyrldopyrimidine) 3,15 3.15 (sc, 3H ; (sc, 3H; pypfôľ) pypfôľ) 2,35 2.35 (t, 2H; (t, 2H; CH v pyridcipyrimidin) CH in pyridcipyrimidine) 2,75 2.75 (sc, 2H; (sc, 2H; etylén, ) ethylene,) 2,55 2.55 (sc, 2H; (sc, 2H; etylén ) ethylene) 2,30 2.30 (s, 3K; (s, 3K; CH 3) CH 3) 2,10 2.10 (sc, 4H; (sc, 4H; P y p er - . P y r i d 0 p y r x m - ) P y p er -. P y r d 0 p y r x m -) 1,90 1.90 (sc, 6H; (sc, 6H; PyPer-, PyridcPyrim-) PyPer-, PyridcPyrim-) Elementárna analýza pre Cp-^HpryFN^O Elemental analysis for C C- ^HryryFN ^O O /molekulová hmotnosí: / molecular weight: 41 0,49/ vypočítané /£/: c 67,30 41 0,49 / Calc'd (?): c 67.30 H 6,63 H, 6.63 F 4,63 J 13,65 j F 4.63 J 13.65 J nájdené /%/: 0 66,16 found (%): 0 66.16 K 6,70 K 6.70 F 4,57 J 13,72 j F 4.57 J 13.72 J Priemyselná využitelnosí Industrial applications

Nový spôsob prípravy 3-£2-[4-(6-fluórbenzofdJizoxazol3-.yl)piperidin-1 -yl] etyl}-2-metyl-6,7,8,9-tetrahydro-4H-pyrido Jý ,2-a]pyrimidin-4-ónu, ktorý má farmaceutické využitie kvôli svojim antipsychotickým vlastnostiam, vychádzajúci z 3-(2-aminoetyl)-2-metyl-6,7,8,9-tetrahydro-4H-pyridofl,2-a] pyrimidin-4-ónu.A novel process for the preparation of 3- [2- [4- (6-fluorobenzophidisoxazol-3-yl) piperidin-1-yl] ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] Pyrimidin-4-one having pharmaceutical utility due to its antipsychotic properties, starting from 3- (2-aminoethyl) -2-methyl-6,7,8,9-tetrahydro-4H-pyridof1,2-a] pyrimidine- 4-one.

Claims (7)

PATENTOVÉ NÁROKYPATENT CLAIMS 1. Spôsob prípravy 3-{2-[4-(6-fluórbenzo[d]izoxazol-3-yl) piperidin-1-yl]etyl} -2-metyl-6,7,8,9-tetrahydro-4H-pyrido[1 ,2-a] pyrimidin-4-ónu vzorca I vyznačujúci sa govať 3-(2-aminoetyl)-2-metyl-6 [1 ,2-a] pyrimidin-4-ón vzorca II vzorca III, tým, že sa necháva rea7,8,9-tetrahydro-4H-p,yridoso zlúčeninou všeobecnéhoProcess for the preparation of 3- {2- [4- (6-fluorobenzo [d] isoxazol-3-yl) piperidin-1-yl] ethyl} -2-methyl-6,7,8,9-tetrahydro-4H- pyrido [1,2-a] pyrimidin-4-one of formula I characterized by 3- (2-aminoethyl) -2-methyl-6 [1,2-a] pyrimidin-4-one of formula II, The reaction is carried out by reacting the compound 7,8,9-tetrahydro-4H-p-yridoso with a general compound NH2 dl) kde znamená Y a Z rovnaké alebo navzájom odlišné uvoíňované skupiny, ako napríklad atóm halogénu alebo alkyLovú skupinu alebo arylsulfonyloxyskupinu v prítomnosti rozpúšťadla a zásady.NH 2 dl) wherein Y and Z are the same or different leaving groups, such as halogen or alkyl or arylsulfonyloxy in the presence of a solvent and a base. 2. Spôsob podlá nároku 1,vyznačujúci ' sa tým, že sa reakcia uskutočňuje v polárnom rozpúšťadle, ako v alkohole s nízkou molekulovou hmotnosťou, ako je nat príklad metanol, etanol, izopropylalkohol alebo n-butanol, s výhodou v etanole alebo v polárnom aprótňom l··rozpúšťadle, ako je napríklad acetonitril, N,N-dimetylformamid alebo N-metylpyrolidón, s výhodou v acetonitrile.The process according to claim 1, characterized in that the reaction is carried out in a polar solvent such as a low molecular weight alcohol such as methanol, ethanol, isopropyl alcohol or n-butanol, preferably ethanol or polar aprotic. a solvent such as acetonitrile, N, N-dimethylformamide or N-methylpyrrolidone, preferably in acetonitrile. II - 19- 19 3· Spôsob podlá nárokov la 2, vyznačujúci sa t ý m , že sa reakcia uskutočňuje v prítomnosti organickej’ zásady, ako je terciárny alebo heterocyklický smín, s vý- hodou v trietylamíne, alebo v prítomnosti anorganickej zásady, ako je hydroxid, uhličitan alebo hydrogenuhličitan alkalického kovu alebo ich zmes, s výhodou v prítomnosti hydrogenuhličítanú sodného.Process according to claims 1 and 2, characterized in that the reaction is carried out in the presence of an organic base, such as a tertiary or heterocyclic amine, preferably in triethylamine, or in the presence of an inorganic base, such as hydroxide, carbonate or an alkali metal bicarbonate or mixture thereof, preferably in the presence of sodium bicarbonate. 4. Spôsob pódia nároku 1, 2 a 3, vyznačujúci sa t ý m. , že sa reakcia uskutočňuje pri teplote 40 až 12O°C, s výhodou pri teplote približne 80°C·4. A method according to claim 1, 2 and 3. that the reaction is carried out at a temperature of 40 to 120 ° C, preferably at a temperature of about 80 ° C; 5. Spôsob pódia nároku 1, 2, 3,a 4> bv y z n a č u j ú ci sa t ý m „ že sa necháva reagoval zlúčenina všeobecného vzorca III, kde uvoľňovanými skupinami symbolu Y a Z sú s výhodou atóm jódu a metáňsulfonyloxyskupina.5. The process according to claim 1, 2, 3, and 4, wherein a compound of formula III is reacted, wherein the Y and Z groups released are preferably iodine and methanesulfonyloxy. 6. 3~(2-Aminoetyl)-2-metyl-6,7,8,9-tetrahydro-4H-pyrido[l, 2-aJ pyrimidin-4-ón vzorca II, reaktívny medziprodukt na spôsob prípravy 3- {2- [4-(6-fluórbenzo [d]izoxazol-3-yl) piperidin1-yl] etyl}-2-metyl-6,7»8,9--tetrahydro-4H-pyridoíl,2-a] pyrimidin-4-ónu vzorca I pódia nárokov 1 až 5.6. 3- (2-Aminoethyl) -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one of formula II, a reactive intermediate for the preparation of 3- {2 - [4- (6-fluorobenzo [d] isoxazol-3-yl) piperidin-1-yl] ethyl} -2-methyl-6,7,8,9-tetrahydro-4H-pyrido [2-a] pyrimidin-4 -one of formula I according to claims 1 to 5. 7. Zlúčenina všeobecného vzorca m, kde znamená · Y; a .Z rovnaké alebo navzájom odlišné uvoiňpvané..; skupiny, ako napríklad-, atóm halogénu alebo skupinu alkýlovú alebo arylsulfonyloxyskupinu, reaktívny medziprodukt na spôsob prípravy 3- [2-[4-(ô-fluórbeazo[d]izoxazol-3-yl) piperidin-1-yl]etyl}-2-metyl-6,7,8,9-tetrahydro-4H-pyrido[l,2-a]pyrimidin-4-ónu vzorca I pódia nárokov 1 až 5·7. A compound of formula m wherein Y is Y ; a. From the same or different loosened ones; groups such as -, a halogen atom or an alkyl or arylsulfonyloxy group, a reactive intermediate for the preparation of 3- [2- [4- (6-fluorobeazo [d] isoxazol-3-yl) piperidin-1-yl] ethyl} -2 - methyl-6,7,8,9-tetrahydro-4H-pyrido [1,2-a] pyrimidin-4-one of the formula I as claimed in claims 1 to 5;
SK156-95A 1994-02-11 1995-02-07 Method for preparation of 3-{2-[4-(6-fluorine-benzo [d] isoxasol-3-yl)piperidine-1-yl]ethyl}-2-methyl-6,7,8,9- tetrahydro-4h-pyridol[1,2-a]pyrimidin-4-one and intermediates of this method SK281752B6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09400252A ES2074966B1 (en) 1994-02-11 1994-02-11 PROCEDURE FOR OBTAINING 3- (2- (4- (6-FLUORO-BENZO (D) ISOXAZOL-3-IL) PIPERIDIN-1-IL) -ETIL) -2-METHYL-6,7,8,9- TETRAHIDRO-4H-PIRIDO- (1,2-A) PIRIMIDIN-4-ONA.

Publications (2)

Publication Number Publication Date
SK15695A3 true SK15695A3 (en) 1995-10-11
SK281752B6 SK281752B6 (en) 2001-07-10

Family

ID=8285178

Family Applications (1)

Application Number Title Priority Date Filing Date
SK156-95A SK281752B6 (en) 1994-02-11 1995-02-07 Method for preparation of 3-{2-[4-(6-fluorine-benzo [d] isoxasol-3-yl)piperidine-1-yl]ethyl}-2-methyl-6,7,8,9- tetrahydro-4h-pyridol[1,2-a]pyrimidin-4-one and intermediates of this method

Country Status (14)

Country Link
KR (1) KR100221108B1 (en)
AT (1) AT405401B (en)
CZ (1) CZ286398B6 (en)
EG (1) EG20877A (en)
ES (1) ES2074966B1 (en)
FI (1) FI110000B (en)
GR (1) GR1002344B (en)
HU (1) HU222110B1 (en)
IS (1) IS1766B (en)
NO (1) NO306022B1 (en)
PL (1) PL181420B1 (en)
PT (1) PT101654B (en)
RU (1) RU2123004C1 (en)
SK (1) SK281752B6 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2101646B1 (en) * 1995-04-12 1998-04-01 Ferrer Int NEW COMPOUND DERIVED FROM CHROMENE.
ES2144355B1 (en) * 1997-12-30 2001-01-01 Ferrer Int COMPOUNDS DERIVED FROM THE CHROME.
EP1280804B1 (en) * 2000-05-05 2004-04-14 RPG Life Sciences Limited A process for the preparation of anti-psychotic 3- 2- 4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4h-pyrido 1,2,-a]pyrimidin-4-one
EP1317434A4 (en) 2000-08-14 2005-06-22 Teva Pharma Preparation of risperidone
KR20040034996A (en) 2002-10-18 2004-04-29 한미약품 주식회사 Improved method for the preparation of risperidone
EP1560814A1 (en) 2002-11-13 2005-08-10 Synthon B.V. Process for making risperidone and intermediates therefor
JP5315336B2 (en) * 2007-04-19 2013-10-16 又欣 李 Novel compounds for the treatment of psychiatric disorders and their preparation and use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352811A (en) * 1981-11-12 1982-10-05 Hoechst-Roussel Pharmaceuticals Inc. 3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US4980365A (en) * 1987-07-13 1990-12-25 Hoechst-Roussel Pharmaceuticals Inc. N-substituted-5,6-dimethoxy-1,2-benzisoxazole-3-propanamine and related compounds as analgesic and hypotensive agents

Also Published As

Publication number Publication date
FI950579A0 (en) 1995-02-10
RU95101859A (en) 1997-03-20
HU9500418D0 (en) 1995-03-28
NO950501D0 (en) 1995-02-09
KR100221108B1 (en) 1999-09-15
PT101654A (en) 1995-09-12
PL307200A1 (en) 1995-08-21
CZ32995A3 (en) 1995-09-13
ATA24995A (en) 1998-12-15
SK281752B6 (en) 2001-07-10
EG20877A (en) 2000-05-31
ES2074966B1 (en) 1996-06-16
NO950501L (en) 1995-08-14
HUT70169A (en) 1995-09-28
AT405401B (en) 1999-08-25
CZ286398B6 (en) 2000-04-12
RU2123004C1 (en) 1998-12-10
PL181420B1 (en) 2001-07-31
KR950032196A (en) 1995-12-20
GR1002344B (en) 1996-05-24
HU222110B1 (en) 2003-04-28
NO306022B1 (en) 1999-09-06
ES2074966A1 (en) 1995-09-16
FI950579A (en) 1995-08-12
IS1766B (en) 2001-03-15
FI110000B (en) 2002-11-15
IS4259A (en) 1995-08-12
PT101654B (en) 2002-01-30

Similar Documents

Publication Publication Date Title
ES2534859T3 (en) Derivatives of indazole, benzoxazole and pyrazolopyridine as p38 kinase inhibitors
JP4437004B2 (en) 2-Butyl-3- (4- [3- (dibutylamino) propoxy] benzoyl) -5-nitrobenzofuran hydrochloride and its preparation
US9776961B2 (en) Crystal of pyrrole derivative and method for producing the same
PL214032B1 (en) P38 inhibitors and methods of use thereof
SK282407B6 (en) N-(4-piperidinyl)(dihydrobenzofuran or dihydro-2h-benzopyran)carboxamide derivatives
US20080214835A1 (en) Processes for preparing darifenacin hydrobromide
HU210870A9 (en) Pyrazolopyrimidinone antianginal agents
JP6268093B2 (en) Process for producing fused heterocyclic derivative and production intermediate thereof
HU181884B (en) Process for preparing new pyrimido/6,1-a/isoquinolin-4-one derivatives
EA008801B1 (en) Aryl alkyl carbamate derivatives production and use thereof in therapy
SK15695A3 (en) Preparing method of 3{2-£4-(6-fluorobenzo £d|-isoxazole-3-yl piperidine-1-yl| ethyl}-2-methyl-6,7,8,9-tetrahydro-4-h-pyridole pyridole £1,2-a| pyrimidine-4-on
FI91064C (en) Process for the preparation of therapeutically active 3- (N-acylethylaminoalkyl) chromanes and -1,4-dioxanes
JP2009543837A (en) Indole compound having affinity for EP1 receptor
WO2015018289A1 (en) Novel method for synthesizing key intermediate of apixaban
US4873340A (en) Process for preparing 5-aroyl-1,2-dihydro-3H-pyrrolo[1,2-A]pyrrole-1,1-dicarboxylates
DK155938B (en) ANALOGY PROCEDURE FOR PREPARING BENZISOXAZOLD DERIVATIVES
US4988822A (en) Intermediates for preparing 5-aroyl-1,2-dihydro-3H-pyrrolo(1,2-A)pyrrole-1,1-dicarboxylates
HRP20020471A2 (en) Process for the preparation of 6-methyl-2-(4-methyl-phenyl)-imidazo[1,2-a]pyrimidine-3-(n,n-dimethyl-acetamide) and intermediates
TWI454470B (en) Method for producing thiabenzoazulene propionic acid derivatives
JPWO2006129781A1 (en) Method for producing dibenzoxepin derivative
CA1340404C (en) Process for preparing (+) -1,2-dihydro-3h-pyrrolo (1, 2-a) pyrrole-1,7-dicarboxylates
EP2528900B1 (en) Synthesis of substituted pyrazoline carboxamidine derivatives
SAIGA et al. Synthesis of 1, 2, 3, 4-tetrahydro-β-carboline derivatives as hepatoprotective agents. IV. Positional isomers of 1, 2, 3, 4-tetrahydro-2-methylthiothiocarbonyl-β-carboline-3-carboxylic acid and its 1-alkylated derivatives
CN114907315A (en) Synthesis method of Selitrectinib intermediate
NO164976B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3- (PIPERIDINYL) -1H-INDAZOLES.

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20110207